The cod farming industry is of growing importance in northern latitude countries such as Norway due to the fish's high demand, declining wild stock, and relatively fast growth at low temperatures. In 2008, the Norwegian Centre for Ecological and Evolutionary Synthesis (CEES) was awarded the funds to complete the sequencing of the 0.9 Gb cod genome and the consortium turned to 454 Life Science to take on the project.
"The cod is a large and complex eukaryote with a number of highly repetitive regions in its genome. We understood the value of long 400-base sequencing reads to get the quality of assembly required to achieve our research goals. In the end, we were able to generate 25x genome coverage and an assembly with few, large scaffolds, a major achievement given the diploid and non-inbred nature of our DNA source," explained Kjetill Jakobsen, Professor at the University of Oslo and consortium leader. "A preliminary transcriptome survey revealed that 95% of all sequenced transcripts are found in the current version of the assembly, confirming the quality of these results. With this project, we have made significant steps towards the creation of a highly annotated reference genome that can be mined for genes and genetic variations associated with important traits for cod aquaculture."
In the next phase of the project, the consortium plans to continue to sequence the cod transcriptome using the Genome Sequencer FLX System for genome annotation and to investigate specimens from various wild cod stocks. "In these follow-up studies we will be searching for SNP and traits relevant to aquaculture, such as sexual maturity, temperature tolerance, oxygen uptake, as well as fishery related traits such as growth in response to harvesting," explained Jakobsen. "Previous studies have shown that if the large cod are harvested from a population of fish, the subsequent offspring population tends to grow smaller. We plan to explore the genetic basis of this evolutionary response."
"This study, along with other recently announced large genome project such as the oil palm, demonstrate that the technology of the 454 Sequencing System has effectively replaced Sanger technology for de novo genome sequencing and assembly," said Christopher McLeod, President and CEO of 454 Life Sciences. "We are extremely excited to continue to work with the cod genome consortium to analyze this important fish species."
For more information on the 454 Sequencing System, visit www.454.com.